Today, we are at the forefront of developing modern and affordable medicines.
We currently operate in 50 markets, targeting a population of more than 1 billion people. Zentiva holds leading positions in several pharmaceutical markets, such as the Czech Republic, Romania and Turkey and is successfully expanding its business in other international markets.
Our success has been built on close and strong relations with key business partners, physicians, pharmacists and patients. Zentiva is committed to delivering generic medicines and providing access to a range of educational and support programs.
Our broad product portfolio covers the main therapeutic areas. Our key product groups include anti-infectives and medicines for cardiovascular disease, pain, central nervous system disorders, female healthcare and gastrointestinal disease.
Zentiva has three key production plants in Central and Eastern Europe, enabling it to manufacture and distribute products across all its markets quickly and efficiently. We maintain the highest product quality and security standards across our manufacturing and supply lines. Our modern state-of-the-art facilities employ more than 2,000 people and produce an annual output of 450 million units, making Zentiva one of the largest producers of pharmaceuticals, by volume, in Europe.
Zentiva is a key element of Sanofis’ strategy, delivering affordable and trusted medicines, to patients and healthcare providers across Europe. www.sanofi.com
Last update: 10/7/2015 3:17 PM